PMS-FINGOLIMOD DIN 02469782
Status: Marketed
Holder: PHARMASCIENCE INC
Molecule: FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE)
Available to quote
Health Canada record
| Active ingredient(s) | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) 0.5 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L04AE01 FINGOLIMOD |
| Original market date | 30-Aug-2019 |
| Current status date | 30-Aug-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02475669 | ACH-FINGOLIMOD | ACCORD HEALTHCARE INC | Capsule | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) 0.5 MG | Marketed |
| 02500914 | ASN-FINGOLIMOD | ASCEND LABORATORIES LTD | Capsule | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) 0.5 MG | Approved |
| 02365480 | GILENYA | NOVARTIS PHARMACEUTICALS CANADA INC | Capsule | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) 0.5 MG | Marketed |
| 02482533 | GILENYA | NOVARTIS PHARMACEUTICALS CANADA INC | Capsule | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) 0.25 MG | Marketed |
| 02487772 | JAMP FINGOLIMOD | JAMP PHARMA CORPORATION | Capsule | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) 0.5 MG | Marketed |
| 02469715 | MYLAN-FINGOLIMOD | MYLAN PHARMACEUTICALS ULC | Capsule | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) 0.5 MG | Marketed |
| 02482606 | SANDOZ FINGOLIMOD | SANDOZ CANADA INCORPORATED | Capsule | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) 0.5 MG | Marketed |
| 02469618 | TARO-FINGOLIMOD | TARO PHARMACEUTICALS INC | Capsule | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) 0.5 MG | Marketed |
| 02469936 | APO-FINGOLIMOD | APOTEX INC | Capsule | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) 0.5 MG | Dormant |
| 02474743 | MAR-FINGOLIMOD | MARCAN PHARMACEUTICALS INC | Capsule | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) 0.5 MG | Dormant |
| 02469561 | TEVA-FINGOLIMOD | TEVA CANADA LIMITED | Capsule | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) 0.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21939 | 2019-03-11 | Abbreviated New Drug Submission (ANDS) |